AG
EXAS

Aperio Group’s Exact Sciences EXAS Stock Holding History

Aperio Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$6.26M Buy
47,288
+6,942
+17% +$840K 0.02% 729
2020
Q3 		$4.11M Buy
40,346
+1,321
+3% +$114K 0.01% 806
2020
Q2 		$3.39M Buy
39,025
+8,141
+26% +$650K 0.01% 884
2020
Q1 		$1.79M Buy
30,884
+2,795
+10% +$227K 0.01% 1064
2019
Q4 		$2.6M Sell
28,089
-4,032
-13% -$354K 0.01% 979
2019
Q3 		$2.9M Buy
32,121
+4,108
+15% +$468K 0.01% 903
2019
Q2 		$3.31M Buy
28,013
+5,834
+26% +$588K 0.01% 862
2019
Q1 		$1.92M Sell
22,179
-1,905
-8% -$162K 0.01% 1055
2018
Q4 		$1.52M Buy
24,084
+9,090
+61% +$624K 0.01% 1097
2018
Q3 		$1.18M Buy
14,994
+404
+3% +$26.3K 0.01% 1311
2018
Q2 		$873K Buy
14,590
+474
+3% +$25.5K ﹤0.01% 1472
2018
Q1 		$570K Buy
14,116
+99
+0.7% +$4.83K ﹤0.01% 1633
2017
Q4 		$737K Buy
14,017
+7,208
+106% +$385K ﹤0.01% 1495
2017
Q3 		$321K Sell
6,809
-322
-5% -$13K ﹤0.01% 1889
2017
Q2 		$252K Buy
+7,131
New +$220K ﹤0.01% 1989

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Aperio Group's EXAS Position: Q4 2020 in Review

Aperio Group increased its Exact Sciences (EXAS) stake by 17% in Q4 2020, buying an estimated $840K and bringing the position to 47,288 shares worth $6.26M. The position accounts for 0.02% of the portfolio, ranked #729.

Aperio Group first reported a position in EXAS in Q2 2017 and has held it in 15 quarters since. 621 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • Aperio Group held 47,288 shares of Exact Sciences worth $6.26M as of Q4 2020.
  • Aperio Group bought 6,942 Exact Sciences shares in Q4 2020, an estimated $840K.
  • Exact Sciences made up 0.02% of Aperio Group's portfolio in Q4 2020, its #729 holding.
  • Aperio Group first reported a position in Exact Sciences in Q2 2017 and has held it in 15 quarters since.
  • 621 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.